202 related articles for article (PubMed ID: 27737336)
21. Antibacterial activity of ZnO and CuO nanoparticles against gram positive and gram negative strains.
Dadi R; Azouani R; Traore M; Mielcarek C; Kanaev A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109968. PubMed ID: 31500003
[TBL] [Abstract][Full Text] [Related]
22. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
23. Bacteriocin-Based Synergetic Consortia: a Promising Strategy to Enhance Antimicrobial Activity and Broaden the Spectrum of Inhibition.
Soltani S; Biron E; Ben Said L; Subirade M; Fliss I
Microbiol Spectr; 2022 Feb; 10(1):e0040621. PubMed ID: 35170996
[TBL] [Abstract][Full Text] [Related]
24. Synergistic antibacterial effects of exopolysaccharides/nickel-nanoparticles composites against multidrug-resistant bacteria.
Garza-Cervantes JA; Mendiola-Garza G; León-Buitimea A; Morones-Ramírez JR
Sci Rep; 2023 Dec; 13(1):21519. PubMed ID: 38057583
[TBL] [Abstract][Full Text] [Related]
25. Silver nanoparticles functionalized with ampicillin.
Rogowska A; Rafińska K; Pomastowski P; Walczak J; Railean-Plugaru V; Buszewska-Forajta M; Buszewski B
Electrophoresis; 2017 Nov; 38(21):2757-2764. PubMed ID: 28704596
[TBL] [Abstract][Full Text] [Related]
26. Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes.
Abioye A; Sanyaolu A; Dudzinska P; Adepoju-Bello AA; Coker HAB
Pharm Nanotechnol; 2020; 8(1):33-53. PubMed ID: 31642799
[TBL] [Abstract][Full Text] [Related]
27. Role of silver doping on the defects related photoluminescence and antibacterial behaviour of zinc oxide nanoparticles.
Kumar V; Prakash J; Singh JP; Chae KH; Swart C; Ntwaeaborwa OM; Swart HC; Dutta V
Colloids Surf B Biointerfaces; 2017 Nov; 159():191-199. PubMed ID: 28793230
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
Tempera G; Mangiafico A; Genovese C; Giudice E; Mastrojeni S; Nicolosi D; Ferneri PM
Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of decreased susceptibility for Gram-negative bacteria and synergistic effect with ampicillin of indole-3-carbinol.
Sung WS; Lee DG
Biol Pharm Bull; 2008 Sep; 31(9):1798-801. PubMed ID: 18758080
[TBL] [Abstract][Full Text] [Related]
30. In vitro assessment of the antimicrobial activity of silver and zinc oxide nanoparticles against fish pathogens.
Shaalan MI; El-Mahdy MM; Theiner S; El-Matbouli M; Saleh M
Acta Vet Scand; 2017 Jul; 59(1):49. PubMed ID: 28732514
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
Mun SH; Joung DK; Kim YS; Kang OH; Kim SB; Seo YS; Kim YC; Lee DS; Shin DW; Kweon KT; Kwon DY
Phytomedicine; 2013 Jun; 20(8-9):714-8. PubMed ID: 23537748
[TBL] [Abstract][Full Text] [Related]
32. Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates.
Huovinen P; Wolfson JS; Hooper DC
Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):255-7. PubMed ID: 1597204
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Schmalreck AF; Wildfeuer A
Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
[TBL] [Abstract][Full Text] [Related]
34. The effect of nickel ions on the susceptibility of bacteria to ciprofloxacin and ampicillin.
Pavlić A; Gobin I; Begić G; Tota M; Abram M; Špalj S
Folia Microbiol (Praha); 2022 Aug; 67(4):649-657. PubMed ID: 35353362
[TBL] [Abstract][Full Text] [Related]
35. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
[TBL] [Abstract][Full Text] [Related]
36. [Interaction of neomycin with other antibiotics on selected bacterial strains].
Grzybowska W; Wójcik A; Tyski S
Med Dosw Mikrobiol; 2004; 56(2):187-98. PubMed ID: 15544091
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against
Fadwa AO; Alkoblan DK; Mateen A; Albarag AM
Saudi J Biol Sci; 2021 Jan; 28(1):928-935. PubMed ID: 33424384
[No Abstract] [Full Text] [Related]
38. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs.
Stepanović S; Antić N; Dakić I; Svabić-Vlahović M
Microbiol Res; 2003; 158(4):353-7. PubMed ID: 14717457
[TBL] [Abstract][Full Text] [Related]
39. In vitro antibacterial activity of zinc oxide on a broad range of reference strains of intestinal origin.
Liedtke J; Vahjen W
Vet Microbiol; 2012 Nov; 160(1-2):251-5. PubMed ID: 22673319
[TBL] [Abstract][Full Text] [Related]
40. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.
Petersen PJ; Labthavikul P; Jones CH; Bradford PA
J Antimicrob Chemother; 2006 Mar; 57(3):573-6. PubMed ID: 16431863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
